Adrian Felipe Hernandez, MD

Publications

Mentz, Robert J., M Angelyn Bethel, Peter Merrill, Yuliya Lokhnygina, John B. Buse, Juliana C. Chan, João S. Felício, et al. “Effect of Once-Weekly Exenatide on Clinical Outcomes According to Baseline Risk in Patients With Type 2 Diabetes Mellitus: Insights From the EXSCEL Trial..” J Am Heart Assoc 7, no. 19 (October 2, 2018). https://doi.org/10.1161/JAHA.118.009304.

PMID
30371301
Full Text

Warraich, Haider J., Haolin Xu, Adam D. DeVore, Roland Matsouaka, Paul A. Heidenreich, Deepak L. Bhatt, Adrian F. Hernandez, Clyde W. Yancy, Gregg C. Fonarow, and Larry A. Allen. “Trends in Hospice Discharge and Relative Outcomes Among Medicare Patients in the Get With The Guidelines-Heart Failure Registry..” Jama Cardiol 3, no. 10 (October 1, 2018): 917–26. https://doi.org/10.1001/jamacardio.2018.2678.

PMID
30167645
Full Text

Reed, S. D., Y. Li, H. Dakin, F. Becker, J. Leal, S. M. Gustavson, B. Kartman, et al. “Impact of exenatide on medical costs and health utilities in type 2 diabetes: experience from EXSCEL.” In Diabetologia, 61:S426–S426. SPRINGER, 2018.

Scholars@Duke

Becker, F., H. Dakin, S. D. Reed, Y. Li, J. Leal, S. M. Gustavson, B. Kartman, et al. “Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial.” In Diabetologia, 61:S366–S366. SPRINGER, 2018.

Scholars@Duke

Buse, J. B., M. A. Bethel, R. A. Patel, S. R. Stevens, S. M. Gustavson, Y. Lokhnygina, A. F. Hernandez, and R. R. Holman. “Potential impact of differential drop-in of open-label diabetes medications in EXSCEL.” In Diabetologia, 61:S21–22. SPRINGER, 2018.

Scholars@Duke

Katona, B., M. A. Bethel, R. Patel, V. P. Thompson, S. M. Gustavson, P. Ohman, N. Iqbal, J. B. Buse, A. F. Hernandez, and R. R. Holman. “Changes in serum calcitonin concentrations and incidence of adjudicated medullary thyroid carcinoma in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).” In Diabetologia, 61:S376–S376. SPRINGER, 2018.

Scholars@Duke

Hernandez, A. F., M. A. Bethel, G. L. Bakris, P. Merrill, S. M. Gustavson, B. G. Katona, P. Ohman, Y. Lokhnygina, R. J. Mentz, and R. R. Holman. “Cardiovascular safety and efficacy of exenatide once-weekly in patients with moderate renal dysfunction in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).” In Diabetologia, 61:S38–S38. SPRINGER, 2018.

Scholars@Duke

Bhatt, Ankeet S., Li Liang, Adam D. DeVore, Gregg C. Fonarow, Scott D. Solomon, Orly Vardeny, Clyde W. Yancy, et al. “Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure..” Jacc Heart Fail 6, no. 10 (October 2018): 844–55. https://doi.org/10.1016/j.jchf.2018.04.012.

PMID
30098960
Full Text

Greene, Stephen J., Adrian F. Hernandez, Jie-Lena Sun, Javed Butler, Paul W. Armstrong, Justin A. Ezekowitz, Faiez Zannad, et al. “Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points..” Circ Cardiovasc Qual Outcomes 11, no. 10 (October 2018). https://doi.org/10.1161/CIRCOUTCOMES.118.004783.

PMID
30354576
Full Text

Green, Jennifer B., Adrian F. Hernandez, Ralph B. D’Agostino, Chris B. Granger, Salim Janmohamed, Nigel P. Jones, Lawrence A. Leiter, et al. “Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-Rationale, design, and baseline characteristics..” Am Heart J 203 (September 2018): 30–38. https://doi.org/10.1016/j.ahj.2018.03.030.

PMID
30015066
Full Text

Pages